PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 86 filers reported holding PASSAGE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $71 | -1.4% | 75 | 0.0% | 0.00% | – |
| Q1 2023 | $72 | -30.8% | 75 | 0.0% | 0.00% | – |
| Q4 2022 | $104 | – | 75 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 75 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 75 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 75 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 75 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 75 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $6,200,000 | 10.57% |
| Lynx1 Capital Management LP | 2,752,422 | $3,441,000 | 3.10% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,235,869 | $1,545,000 | 2.89% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,122,000 | 1.85% |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $4,696,000 | 0.36% |
| Orbimed Advisors | 8,931,999 | $11,165,000 | 0.21% |
| Newtyn Management, LLC | 300,000 | $375,000 | 0.08% |
| Deep Track Capital, LP | 1,439,062 | $1,799,000 | 0.08% |
| Rubric Capital Management LP | 822,105 | $1,028,000 | 0.05% |
| Oasis Management Co Ltd. | 240,000 | $300,000 | 0.05% |